Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays

被引:11
|
作者
Dernick, Gregor [1 ]
Obermueller, Stefan [1 ]
Mangold, Cyrill [1 ]
Magg, Christine [1 ]
Matile, Hugues [1 ]
Gutmann, Oliver [1 ]
von der Mark, Elisabeth [2 ]
Handschin, Corinne [2 ]
Maugeais, Cyrille [2 ]
Niesor, Eric J. [2 ]
机构
[1] F Hoffmann La Roche Ltd, Discovery Technol, Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Metab & Vasc Dis, Basel, Switzerland
关键词
HDL proteomics; protein-protein interaction; protein-lipid interaction; fast protein liquid chromatography; size exclusion chromatography; reverse-phase arrays; HIGH-DENSITY-LIPOPROTEIN; PRE-BETA; APOLIPOPROTEIN-E; CHOLESTEROL; PROTEOMICS; METABOLISM; FPLC;
D O I
10.1194/jlr.D016824
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The composition of lipoproteins and the association of proteins with various particles are of much interest in the context of cardiovascular disease. Here, we describe a technique for the multidimensional analysis of lipoproteins and their associated apolipoproteins. Plasma is separated by size exclusion chromatography (SEC), and fractions are analyzed by reverse-phase arrays. SEC fractions are spotted on nitrocellulose slides and incubated with different antibodies against individual apolipoproteins or antibodies against various apolipoproteins. In this way, tens of analytes can be measured simultaneously in 100 mu l of plasma from a single SEC separation. This methodology is particularly suited to simultaneous analysis of multiple proteins that may change their distribution to lipoproteins or alter their conformation, depending on factors that influence circulating lipoprotein size or composition. We observed changes in the distribution of exchangeable apolipoproteins following addition of recombinant apolipoproteins or interaction with exogenous compounds. While the cholesteryl ester transfer protein (CETP)-dependent formation of pre-beta-HDL was inhibited by the CETP inhibitors torcetrapib and anacetrapib, it was not reduced by the CETP modulator dalcetrapib. This finding was elucidated using this technique.-Dernick, G., S. Obermuller, C. Mangold, C. Magg, H. Matile, O. Gutmann, E. von der Mark, C. Handschin, C. Maugeais, and E. J. Niesor. Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays. J. Lipid Res. 2011. 52: 2323-2331.
引用
收藏
页码:2323 / 2331
页数:9
相关论文
共 50 条
  • [31] Signal pathway profiling of prostate cancer using reverse phase protein arrays
    Grubb, RL
    Calvert, VS
    Wulkuhle, JD
    Paweletz, CP
    Linehan, WM
    Phillips, JL
    Chuaqui, R
    Valasco, A
    Gillespie, J
    Emmert-Buck, M
    Liotta, LA
    Petricoin, EF
    PROTEOMICS, 2003, 3 (11) : 2142 - 2146
  • [32] Signal pathway profiling of prostate cancer using reverse phase protein arrays
    Grubb, RL
    Calvert, VS
    Paweletz, CP
    Phillips, JL
    Linehan, WM
    Gillespie, JW
    Emmert-Buck, MR
    Liotta, LA
    Petricoin, EF
    JOURNAL OF UROLOGY, 2003, 169 (04): : 61 - 61
  • [33] High throughput protein characterization by automated reverse-phase chromatography electrospray tandem mass spectrometry
    Ducret, A
    Van Oostveen, I
    Eng, JK
    Yates, JR
    Aebersold, R
    PROTEIN SCIENCE, 1998, 7 (03) : 706 - 719
  • [34] Global profiling of the RNA and protein complexes of Escherichia coli by size exclusion chromatography followed by RNA sequencing and mass spectrometry (SEC-seq)
    Chihara, Kotaro
    Gerovac, Milan
    Hoer, Jens
    Vogel, Joerg
    RNA, 2023, 29 (01) : 123 - 139
  • [35] Microfluidic Size Exclusion Chromatography (μSEC) for Extracellular Vesicles and Plasma Protein Separation
    Leong, Sheng Yuan
    Ong, Hong Boon
    Tay, Hui Min
    Kong, Fang
    Upadya, Megha
    Gong, Lingyan
    Dao, Ming
    Dalan, Rinkoo
    Hou, Han Wei
    SMALL, 2022, 18 (06)
  • [36] Reverse-phase protein arrays as a tool to discover mutation-associated alterations in cell signaling pathways
    Starmann, J.
    Blaich, S.
    Bender, C.
    Armbruster, H.
    Mannsperger, H.
    Lange, B.
    Korf, U.
    Sueltmann, H.
    EJC SUPPLEMENTS, 2010, 8 (05): : 192 - 192
  • [37] DETERMINATION OF CODEINE IN HUMAN-PLASMA BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    NITSCHE, V
    MASCHER, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (11) : 1556 - 1558
  • [38] Separation and determination of cinoxacin and nalidixic acid in human plasma by reverse-phase high performance liquid chromatography
    Deng, H
    Zhang, HX
    Zhang, JS
    Liu, MC
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2001, 29 (03) : 306 - 308
  • [39] THE USE OF REVERSE-PHASE CHROMATOGRAPHY IN THE RADIOIMMUNOASSAY OF VASOTOCIN (AVT) AND MESOTOCIN (MT) IN PLASMA OF RANA-RIDIBUNDA
    NOUWEN, EJ
    KUHN, ER
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1982, 46 (03) : 390 - 390
  • [40] New treatment options for metastatic breast cancer revealed by reverse-phase protein microarray and genomic profiling
    Williams, Casey B.
    De, Pradip
    Dey, Nandini
    Williams, Kirstin A.
    Klein, Jessica
    King, Michelle
    Small, Misty
    Cyr, Brigitte
    Willis, Scooter
    Sun, Yuliang
    Carlson, Jennifer
    Young, Brandon M.
    Krie, Amy
    Leyland-Jones, Brian
    CANCER RESEARCH, 2015, 75